Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 303

1.

Different Patterns of Left Ventricular Hypertrophy in Metabolically Healthy and Insulin-Resistant Obese Subjects.

Sciacqua A, Cimellaro A, Mancuso L, Miceli S, Cassano V, Perticone M, Fiorentino TV, Andreozzi F, Succurro E, Sesti G, Perticone F.

Nutrients. 2020 Feb 5;12(2). pii: E412. doi: 10.3390/nu12020412.

2.

Metabolic and Cognitive Effects of Ranolazine in Type 2 Diabetes Mellitus: Data from an in vivo Model.

Cassano V, Leo A, Tallarico M, Nesci V, Cimellaro A, Fiorentino TV, Citraro R, Hribal ML, De Sarro G, Perticone F, Sesti G, Russo E, Sciacqua A.

Nutrients. 2020 Jan 31;12(2). pii: E382. doi: 10.3390/nu12020382.

3.

Reduction in Global Myocardial Glucose Metabolism in Subjects With 1-h Postload Hyperglycemia and Impaired Glucose Tolerance.

Succurro E, Pedace E, Andreozzi F, Papa A, Vizza P, Fiorentino TV, Perticone F, Veltri P, Cascini GL, Sesti G.

Diabetes Care. 2020 Jan 23. pii: dc191975. doi: 10.2337/dc19-1975. [Epub ahead of print]

PMID:
31974102
4.

HDL cholesterol is an independent predictor of β-cell function decline and incident type 2 diabetes: A longitudinal study.

Fiorentino TV, Succurro E, Marini MA, Pedace E, Andreozzi F, Perticone M, Sciacqua A, Perticone F, Sesti G.

Diabetes Metab Res Rev. 2020 Jan 10:e3289. doi: 10.1002/dmrr.3289. [Epub ahead of print]

PMID:
31922637
5.

Specific knockout of p85α in brown adipose tissue induces resistance to high-fat diet-induced obesity and its metabolic complications in male mice.

Gomez-Hernandez A, Lopez-Pastor AR, Rubio-Longas C, Majewski P, Beneit N, Viana-Huete V, García-Gómez G, Fernandez S, Hribal ML, Sesti G, Escribano O, Benito M.

Mol Metab. 2020 Jan;31:1-13. doi: 10.1016/j.molmet.2019.10.010. Epub 2019 Nov 9.

6.

A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks: DUAL VIII, a randomized trial designed to resemble clinical practice.

Sesti G, Bardtrum L, Dagdelen S, Halladin N, Haluzík M, Őrsy P, Rodríguez M, Aroda VR.

Diabetes Obes Metab. 2020 Jan 5. doi: 10.1111/dom.13957. [Epub ahead of print]

PMID:
31903724
7.

Relationships of surrogate indexes of insulin resistance with insulin sensitivity assessed by euglycemic hyperinsulinemic clamp and subclinical vascular damage.

Fiorentino TV, Marini MA, Succurro E, Andreozzi F, Sesti G.

BMJ Open Diabetes Res Care. 2019 Nov 13;7(1):e000911. doi: 10.1136/bmjdrc-2019-000911. eCollection 2019.

8.

Immunity, Inflammation and Heart Failure: Their Role on Cardiac Function and Iron Status.

Perticone M, Zito R, Miceli S, Pinto A, Suraci E, Greco M, Gigliotti S, Hribal ML, Corrao S, Sesti G, Perticone F.

Front Immunol. 2019 Oct 1;10:2315. doi: 10.3389/fimmu.2019.02315. eCollection 2019.

9.

Are Circulating Mg2+ Levels Associated with Glucose Tolerance Profiles and Incident Type 2 Diabetes?

Spiga R, Mannino GC, Mancuso E, Averta C, Paone C, Rubino M, Sciacqua A, Succurro E, Perticone F, Andreozzi F, Sesti G.

Nutrients. 2019 Oct 14;11(10). pii: E2460. doi: 10.3390/nu11102460.

10.

A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients.

Mannino GC, Pezzilli S, Averta C, Fuoco A, Spiga R, Mancuso E, Di Fatta C, Perticone F, Prudente S, Trischitta V, Andreozzi F, Sesti G.

Cardiovasc Diabetol. 2019 Aug 13;18(1):102. doi: 10.1186/s12933-019-0906-1.

11.

Guidelines for the screening and diagnosis of gestational diabetes in Italy from 2010 to 2019: critical issues and the potential for improvement.

Vitacolonna E, Succurro E, Lapolla A, Scavini M, Bonomo M, Di Cianni G, Di Benedetto A, Napoli A, Tumminia A, Festa C, Lencioni C, Torlone E, Sesti G, Mannino D, Purrello F.

Acta Diabetol. 2019 Nov;56(11):1159-1167. doi: 10.1007/s00592-019-01397-4. Epub 2019 Aug 8. Review.

PMID:
31396699
12.

Dulaglutide is an effective treatment for lowering HbA1c in patients with type 2 diabetes regardless of body mass index.

Gentilella R, Sesti G, Vazquez L, Sapin H, Reed V, Romera I, Pozzilli P.

Diabetes Obes Metab. 2019 Dec;21(12):2660-2666. doi: 10.1111/dom.13853. Epub 2019 Aug 28.

PMID:
31392822
13.

Ketogenic Diet-Induced Weight Loss is Associated with an Increase in Vitamin D Levels in Obese Adults.

Perticone M, Maio R, Sciacqua A, Suraci E, Pinto A, Pujia R, Zito R, Gigliotti S, Sesti G, Perticone F.

Molecules. 2019 Jul 9;24(13). pii: E2499. doi: 10.3390/molecules24132499.

14.

Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial.

Aroda VR, González-Galvez G, Grøn R, Halladin N, Haluzík M, Jermendy G, Kok A, Őrsy P, Sabbah M, Sesti G, Silver R.

Lancet Diabetes Endocrinol. 2019 Aug;7(8):596-605. doi: 10.1016/S2213-8587(19)30184-6. Epub 2019 Jun 9.

PMID:
31189519
15.

Change in HbA1c Across the Baseline HbA1c Range in Type 2 Diabetes Patients Receiving Once-Weekly Dulaglutide Versus Other Incretin Agents.

Gentilella R, Romera I, Nicolay C, Buzzetti R, Vázquez LA, Sesti G.

Diabetes Ther. 2019 Jun;10(3):1113-1125. doi: 10.1007/s13300-019-0625-3. Epub 2019 May 4.

16.

The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes: A consensus view of Italian diabetes experts using the Delphi method.

Bruttomesso D, Laviola L, Avogaro A, Bonora E, Del Prato S, Frontoni S, Orsi E, Rabbone I, Sesti G, Purrello F; of the Italian Diabetes Society (SID).

Nutr Metab Cardiovasc Dis. 2019 May;29(5):421-431. doi: 10.1016/j.numecd.2019.01.018. Epub 2019 Feb 10.

17.

Fine-scale haplotype mapping of MUT, AACS, SLC6A15 and PRKCA genes indicates association with insulin resistance of metabolic syndrome and relationship with branched chain amino acid metabolism or regulation.

Haydar S, Grigorescu F, Vintilă M, Cogne Y, Lautier C, Tutuncu Y, Brun JF, Robine JM, Pugeat M, Normand C, Poucheret P, Gheorghiu ML, Georgescu C, Badiu C, Băculescu N, Renard E, Ylli D, Badiou S, Sutra T, Cristol JP, Mercier J, Gomis R, Macias JM, Litvinov S, Khusnutdinova E, Poiana C, Pasquali R, Lauro D, Sesti G, Prudente S, Trischitta V, Tsatsoulis A, Abdelhak S, Barakat A, Zenati A, Ylli A, Satman I, Kanninen T, Rinato Y, Missoni S.

PLoS One. 2019 Mar 26;14(3):e0214122. doi: 10.1371/journal.pone.0214122. eCollection 2019.

18.

Individuals With Prediabetes Display Different Age-Related Pathophysiological Characteristics.

Fiorentino TV, Pedace E, Succurro E, Andreozzi F, Perticone M, Sciacqua A, Perticone F, Sesti G.

J Clin Endocrinol Metab. 2019 Jul 1;104(7):2911-2924. doi: 10.1210/jc.2018-02610.

PMID:
30848793
19.

Elevated 1-h post-load plasma glucose is associated with right ventricular morphofunctional parameters in hypertensive patients.

Sciacqua A, Perticone M, Miceli S, Pinto A, Cassano V, Succurro E, Andreozzi F, Hribal ML, Sesti G, Perticone F.

Endocrine. 2019 Jun;64(3):525-535. doi: 10.1007/s12020-019-01873-5. Epub 2019 Feb 21.

PMID:
30790176
20.

Multi-disciplinary Consensus Statement Document Vaccinal prevention in adult patients with diabetes mellitus.

Icardi G, Francia F, Di Bartolo P, Mannino D, Alti E, Purrello F, Sesti G, Sessa A.

J Prev Med Hyg. 2018 Dec 15;59(4):E249-E256. doi: 10.15167/2421-4248/jpmh2018.59.4.1124. eCollection 2018 Dec. No abstract available.

21.

Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus.

Sesti G, Avogaro A, Belcastro S, Bonora BM, Croci M, Daniele G, Dauriz M, Dotta F, Formichi C, Frontoni S, Invitti C, Orsi E, Picconi F, Resi V, Bonora E, Purrello F.

Acta Diabetol. 2019 Jun;56(6):605-617. doi: 10.1007/s00592-018-1271-3. Epub 2019 Jan 2. Review.

PMID:
30603867
22.

Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine.

Mannino GC, Andreozzi F, Sesti G.

Diabetes Metab Res Rev. 2019 Mar;35(3):e3109. doi: 10.1002/dmrr.3109. Epub 2019 Jan 7. Review.

23.

PCSK9 inhibitor therapy: A systematic review and meta-analysis of metabolic and cardiovascular outcomes in patients with diabetes.

Monami M, Sesti G, Mannucci E.

Diabetes Obes Metab. 2018 Nov 28. doi: 10.1111/dom.13599. [Epub ahead of print]

PMID:
30485622
24.

One-hour post-load hyperglycemia combined with HbA1c identifies individuals with higher risk of cardiovascular diseases: Cross-sectional data from the CATAMERI study.

Fiorentino TV, Succurro E, Andreozzi F, Sciacqua A, Perticone F, Sesti G.

Diabetes Metab Res Rev. 2019 Feb;35(2):e3096. doi: 10.1002/dmrr.3096. Epub 2018 Nov 20.

PMID:
30378248
25.

Branched-Chain Amino Acid Database Integrated in MEDIPAD Software as a Tool for Nutritional Investigation of Mediterranean Populations.

Haydar S, Paillot T, Fagot C, Cogne Y, Fountas A, Tutuncu Y, Vintila M, Tsatsoulis A, Thanh Chi P, Garandeau P, Chetea D, Badiu C, Gheorghiu M, Ylli D, Lautier C, Jarec M, Monnier L, Normand C, Šarac J, Barakat A, Missoni S, Pugeat M, Poucheret P, Hanzu F, Gomis R, Macias JM, Litvinov S, Khusnutdinova E, Poiana C, Pasquali R, Lauro D, Sesti G, Trischitta V, Abdelhak S, Zenati A, Ylli A, Satman I, Kanninen T, Rinato Y, Grigorescu F.

Nutrients. 2018 Oct 1;10(10). pii: E1392. doi: 10.3390/nu10101392.

26.

Petition to replace current OGTT criteria for diagnosing prediabetes with the 1-hour post-load plasma glucose ≥ 155 mg/dl (8.6 mmol/L).

Bergman M, Manco M, Sesti G, Dankner R, Pareek M, Jagannathan R, Chetrit A, Abdul-Ghani M, Buysschaert M, Olsen MH, Nilsson PM, Medina JL, Roth J, Groop L, Del Prato S, Raz I, Ceriello A.

Diabetes Res Clin Pract. 2018 Dec;146:18-33. doi: 10.1016/j.diabres.2018.09.017. Epub 2018 Sep 28. Review.

PMID:
30273707
27.

Response to Letter to the Editor: "One-Hour Postload Hyperglycemia: Implications for Prediction and Prevention of Type 2 Diabetes".

Fiorentino TV, Marini MA, Succurro E, Andreozzi F, Perticone M, Hribal ML, Sciacqua A, Perticone F, Sesti G.

J Clin Endocrinol Metab. 2019 Mar 1;104(3):676-677. doi: 10.1210/jc.2018-01824. No abstract available.

PMID:
30239916
28.

Metabolic and vascular effects of silybin in hypertensive patients with high 1-h post-load plasma glucose.

Sciacqua A, Perticone M, Tripepi G, Addesi D, Cassano V, Maio R, Sesti G, Perticone F.

Intern Emerg Med. 2019 Jan;14(1):77-84. doi: 10.1007/s11739-018-1951-6. Epub 2018 Sep 19.

PMID:
30232738
29.

Serum IgG2 levels are specifically associated with whole-body insulin-mediated glucose disposal in non-diabetic offspring of type 2 diabetic individuals: a cross-sectional study.

Fiorentino TV, Succurro E, Arturi F, Giancotti A, Peronace C, Quirino A, Sesti F, Andreozzi F, Hribal ML, Perticone F, Focà A, Sesti G.

Sci Rep. 2018 Sep 11;8(1):13616. doi: 10.1038/s41598-018-32108-8.

30.

The polymorphism rs35767 at IGF1 locus is associated with serum urate levels.

Mannino GC, Fuoco A, Marini MA, Spiga R, Di Fatta C, Mancuso E, Perticone F, Andreozzi F, Sesti G.

Sci Rep. 2018 Aug 16;8(1):12255. doi: 10.1038/s41598-018-29665-3.

31.

One-Hour Postload Hyperglycemia: Implications for Prediction and Prevention of Type 2 Diabetes.

Fiorentino TV, Marini MA, Succurro E, Andreozzi F, Perticone M, Hribal ML, Sciacqua A, Perticone F, Sesti G.

J Clin Endocrinol Metab. 2018 Sep 1;103(9):3131-3143. doi: 10.1210/jc.2018-00468. Review.

PMID:
30020454
32.

The place of gliclazide MR in the evolving type 2 diabetes landscape: A comparison with other sulfonylureas and newer oral antihyperglycemic agents.

Colagiuri S, Matthews D, Leiter LA, Chan SP, Sesti G, Marre M.

Diabetes Res Clin Pract. 2018 Sep;143:1-14. doi: 10.1016/j.diabres.2018.05.028. Epub 2018 May 24. Review.

PMID:
29802958
33.

Higher serum levels of uric acid are associated with a reduced insulin clearance in non-diabetic individuals.

Fiorentino TV, Sesti F, Succurro E, Pedace E, Andreozzi F, Sciacqua A, Hribal ML, Perticone F, Sesti G.

Acta Diabetol. 2018 Aug;55(8):835-842. doi: 10.1007/s00592-018-1153-8. Epub 2018 May 17.

PMID:
29774469
34.

Uric Acid Impairs Insulin Signaling by Promoting Enpp1 Binding to Insulin Receptor in Human Umbilical Vein Endothelial Cells.

Tassone EJ, Cimellaro A, Perticone M, Hribal ML, Sciacqua A, Andreozzi F, Sesti G, Perticone F.

Front Endocrinol (Lausanne). 2018 Mar 26;9:98. doi: 10.3389/fendo.2018.00098. eCollection 2018.

35.

Use and effectiveness of dapagliflozin in routine clinical practice: An Italian multicentre retrospective study.

Fadini GP, Zatti G, Baldi I, Bottigliengo D, Consoli A, Giaccari A, Sesti G, Avogaro A; DARWIN-T2D network.

Diabetes Obes Metab. 2018 Jul;20(7):1781-1786. doi: 10.1111/dom.13280. Epub 2018 Mar 30.

36.

Potential role of insulin receptor isoforms and IGF receptors in plaque instability of human and experimental atherosclerosis.

Beneit N, Martín-Ventura JL, Rubio-Longás C, Escribano Ó, García-Gómez G, Fernández S, Sesti G, Hribal ML, Egido J, Gómez-Hernández A, Benito M.

Cardiovasc Diabetol. 2018 Feb 20;17(1):31. doi: 10.1186/s12933-018-0675-2.

37.

Management of diabetes in older adults.

Sesti G, Antonelli Incalzi R, Bonora E, Consoli A, Giaccari A, Maggi S, Paolisso G, Purrello F, Vendemiale G, Ferrara N.

Nutr Metab Cardiovasc Dis. 2018 Mar;28(3):206-218. doi: 10.1016/j.numecd.2017.11.007. Epub 2017 Dec 7. Review.

38.

Competitive interaction between chronic obstructive pulmonary disease and CHA2DS2-VASc score in predicting incident atrial fibrillation.

Perticone M, Sciacqua A, Tripepi G, Miceli S, Corrao S, Sesti G, Perticone F.

Int J Cardiol. 2018 Mar 15;255:74-79. doi: 10.1016/j.ijcard.2017.11.036. Epub 2017 Nov 20.

PMID:
29174184
39.

Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction.

Fiorentino TV, Marini MA, Succurro E, Sciacqua A, Andreozzi F, Perticone F, Sesti G.

Oncotarget. 2017 Jun 19;8(45):79576-79586. doi: 10.18632/oncotarget.18572. eCollection 2017 Oct 3.

40.

Association between hemoglobin glycation index and hepatic steatosis in non-diabetic individuals.

Fiorentino TV, Marini MA, Succurro E, Andreozzi F, Sciacqua A, Hribal ML, Perticone F, Sesti G.

Diabetes Res Clin Pract. 2017 Dec;134:53-61. doi: 10.1016/j.diabres.2017.09.017. Epub 2017 Oct 6.

PMID:
28993156
41.

Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity.

Fadini GP, Zatti G, Consoli A, Bonora E, Sesti G, Avogaro A; DARWIN-T2D Network.

Nutr Metab Cardiovasc Dis. 2017 Dec;27(12):1089-1097. doi: 10.1016/j.numecd.2017.08.001. Epub 2017 Aug 8.

PMID:
28967594
42.

Duodenal Sodium/Glucose Cotransporter 1 Expression Under Fasting Conditions Is Associated With Postload Hyperglycemia.

Fiorentino TV, Suraci E, Arcidiacono GP, Cimellaro A, Mignogna C, Presta I, Andreozzi F, Hribal ML, Perticone F, Donato G, Luzza F, Sesti G.

J Clin Endocrinol Metab. 2017 Nov 1;102(11):3979-3989. doi: 10.1210/jc.2017-00348.

PMID:
28938485
43.

Predictors of response to glucagon-like peptide-1 receptor agonists: a meta-analysis and systematic review of randomized controlled trials.

Monami M, Dicembrini I, Nreu B, Andreozzi F, Sesti G, Mannucci E.

Acta Diabetol. 2017 Dec;54(12):1101-1114. doi: 10.1007/s00592-017-1054-2. Epub 2017 Sep 20. Review.

PMID:
28932989
44.

Erratum to: Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials.

Dicembrini I, Nreu B, Scatena A, Andreozzi F, Sesti G, Mannucci E, Monami M.

Acta Diabetol. 2017 Nov;54(11):1069-1071. doi: 10.1007/s00592-017-1049-z.

PMID:
28924916
45.

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial.

Vaccaro O, Masulli M, Nicolucci A, Bonora E, Del Prato S, Maggioni AP, Rivellese AA, Squatrito S, Giorda CB, Sesti G, Mocarelli P, Lucisano G, Sacco M, Signorini S, Cappellini F, Perriello G, Babini AC, Lapolla A, Gregori G, Giordano C, Corsi L, Buzzetti R, Clemente G, Di Cianni G, Iannarelli R, Cordera R, La Macchia O, Zamboni C, Scaranna C, Boemi M, Iovine C, Lauro D, Leotta S, Dall'Aglio E, Cannarsa E, Tonutti L, Pugliese G, Bossi AC, Anichini R, Dotta F, Di Benedetto A, Citro G, Antenucci D, Ricci L, Giorgino F, Santini C, Gnasso A, De Cosmo S, Zavaroni D, Vedovato M, Consoli A, Calabrese M, di Bartolo P, Fornengo P, Riccardi G; Thiazolidinediones Or Sulfonylureas Cardiovascular Accidents Intervention Trial (TOSCA.IT) study group; Italian Diabetes Society.

Lancet Diabetes Endocrinol. 2017 Nov;5(11):887-897. doi: 10.1016/S2213-8587(17)30317-0. Epub 2017 Sep 13. Erratum in: Lancet Diabetes Endocrinol. 2017 Nov;5(11):e7.

PMID:
28917544
46.

Insulin-like growth factor-1 is a negative modulator of glucagon secretion.

Mancuso E, Mannino GC, Fatta CD, Fuoco A, Spiga R, Andreozzi F, Sesti G.

Oncotarget. 2017 Jun 16;8(31):51719-51732. doi: 10.18632/oncotarget.18514. eCollection 2017 Aug 1.

47.

Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials.

Dicembrini I, Nreu B, Scatena A, Andreozzi F, Sesti G, Mannucci E, Monami M.

Acta Diabetol. 2017 Oct;54(10):933-941. doi: 10.1007/s00592-017-1031-9. Epub 2017 Jul 27. Review. Erratum in: Acta Diabetol. 2017 Sep 19;:.

PMID:
28748377
48.

Pharmacogenetics of oral antidiabetes drugs: evidence for diverse signals at the IRS1 locus.

Prudente S, Di Paola R, Pezzilli S, Garofolo M, Lamacchia O, Filardi T, Mannino GC, Mercuri L, Alberico F, Scarale MG, Sesti G, Morano S, Penno G, Cignarelli M, Copetti M, Trischitta V.

Pharmacogenomics J. 2018 May 22;18(3):431-435. doi: 10.1038/tpj.2017.32. Epub 2017 Jul 11.

PMID:
28696414
49.

Plasma kisspeptin levels are associated with insulin secretion in nondiabetic individuals.

Andreozzi F, Mannino GC, Mancuso E, Spiga R, Perticone F, Sesti G.

PLoS One. 2017 Jun 21;12(6):e0179834. doi: 10.1371/journal.pone.0179834. eCollection 2017.

50.

Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity.

Marini MA, Fiorentino TV, Andreozzi F, Mannino GC, Perticone M, Sciacqua A, Perticone F, Sesti G.

Acta Diabetol. 2017 Aug;54(8):775-784. doi: 10.1007/s00592-017-1004-z. Epub 2017 Jun 2.

PMID:
28577138

Supplemental Content

Support Center